Related Experiment Video

Updated: May 29, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Recent aspects of vasculitis and future direction

Gülfidan Aras1

  • 1Yedikule Education and Research Hospital of Chest Diseases, Turkey. gulfidanaras@yahoo.com

Internal Medicine (Tokyo, Japan)
|September 17, 2011
PubMed

Insights

Current vasculitis diagnostics are insufficient. New research into autoantibodies and T cell immunity may lead to improved biomarkers for diagnosing vasculitis and developing novel treatments.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • Vasculitis is characterized by inflammation, vessel destruction, and necrosis.
  • Existing classifications (CHCC, ACR) and biomarkers (PR3-ANCA, MPO-ANCA) have limitations in diagnosing vasculitis, especially small vessel vasculitis, due to insufficient sensitivity and specificity.

Purpose of the Study:

  • To explore recent advancements in vasculitis pathogenesis and etiopathogenesis.
  • To identify potential new biomarkers for improved vasculitis diagnosis.
  • To investigate the role of T cell immunity in vasculitis for future therapeutic development.

Main Methods:

  • Review of current literature on vasculitis pathogenesis, including ANCA roles, synergistic factors (infection, genetics, environment, drugs), and novel autoantibodies.
  • Analysis of findings related to anti-hLAMP-2 autoantibodies and potential links to hepatitis B and C viruses.
  • Examination of evidence regarding circulatory and lesional T cell immunity.

Main Results:

  • Current diagnostic tools for vasculitis are inadequate.
  • New research highlights the potential of novel autoantibodies (e.g., anti-hLAMP-2) and viral associations (Hepatitis B/C) as diagnostic clues.
  • Evidence suggests T cell immunity plays a significant role in vasculitis.

Conclusions:

  • Recent discoveries in vasculitis pathogenesis offer promise for developing more effective diagnostic biomarkers.
  • Further research into ANCA, synergistic factors, and T cell immunity is crucial for advancing vasculitis diagnosis and treatment.
  • Novel autoantibodies and viral links may pave the way for improved diagnostic strategies.

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...